site stats

Haihe biopharma usa llc

Web"HaiHe Biopharma focuses on discovery, development and commercialization of innovative anti-tumor drugs. Guided by our mission, “Inclusive and open to diversity, innovation … WebJul 24, 2024 · Haihe Biopharma has raised a total of $317.6M in funding over 2 rounds. Their latest funding was raised on Jul 24, 2024 from a Series B round. Haihe Biopharma …

Top Haihe Biopharma Competitors and Alternatives Craft.co

WebSep 4, 2024 · HaiHe Biopharma, a biopharmaceutical company focusing on the discovery, development and commercialization of innovative anti-tumor drugs, announced that the company has recently obtained the IND (Investigational New Drug) approval from FDA for HH2710, an extracellular regulated protein kinase (ERK) inhibitor developed by the … WebJul 30, 2024 · Haihe Biopharma Co. Ltd. Headquarters: Shanghai, China Website: http://www.haihepharma.com Year Founded: 2024 Status: Private BioCentury Jul 30, 2024 Finance July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase trailmini by trailmanor https://tuttlefilms.com

HAIHE BIOPHARMA USA LLC

WebDr. Hong joined Hiahe Biopharma in 2024, leading the company’s biostatistics and data science team. He has 17 years of industry experience at multi-national pharmaceutical and biotechnology companies including Eli Lilly, Bristol Myers Squibb, Eisai, Advaxis and Immunomedics, and rich leadership experiences as heads of biostatistics and … WebDr. Hong joined Hiahe Biopharma in 2024, leading the company’s biostatistics and data science team. He has 17 years of industry experience at multi-national pharmaceutical … WebHaihe Biopharma is a private company that has been in the industry for 11 years. The company currently specializes in the Hospital & Health Care, Biotechnology, … trail medication for pulmonary hypertension

HaiHe Biopharma - Products, Competitors, Financials, Employees ...

Category:HaiHe Biopharma Obtains the IND Approval from FDA for Its …

Tags:Haihe biopharma usa llc

Haihe biopharma usa llc

Haihe Biopharma headquarters and office locations - craft.co

WebAug 3, 2024 · Haihe Biopharma is an innovation-driven biotechnology company in China focusing on the discovery, development, production and commercialization of innovative anti-cancer therapies. Haihe brings life-saving drugs to cancer patients worldwide. It has a... Read More Discover more about Haihe Biopharma Jason Sudia Work Experience and … WebDeveloper HaiHe Biopharma Class Antineoplastics; Carbamates; Fluorinated hydrocarbons; Morpholines; Piperazines; Pyridines; Pyrroles; Small molecules; Sulfones; …

Haihe biopharma usa llc

Did you know?

WebJul 15, 2024 · At a glance Originator Advenchen Laboratories; Shanghai Institute of Materia Medica Developer Bristol-Myers Squibb; Clovis Oncology; HaiHe Biopharma; Servier; Shanghai Institute of Materia Medica Class Acetamides; Antineoplastics; Cyclopropanes; Naphthalenes; Phenyl ethers; Quinolines; Small molecules WebHaihe Biopharma USA LLC 1. The Orphan Drug Application and Orphan Drug Designation related records/correspondence for: Capmatinib for treatment of non-small cell lung cancer with MET genomic tumor ...

WebHaihe Biopharma is an innovation-driven biotechnology company in China focusing on the discovery, development, production and commercialization of innovative anti-cancer … WebMar 11, 2011 · Haihe Pharmaceutical, RMX Pharmaceutical Technology Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug …

WebMar 8, 2024 · +86 2120568888 Company Haihe Biopharma RuiPing Dong Current Workplace RuiPing Dong has been working as a Chief Executive Officer at Haihe Biopharma for 5 years. Haihe Biopharma is part of the Manufacturing industry, and located in China. Haihe Biopharma Location 421 Newton Rd Zhangjiang Hi-tech Park, … WebDeveloper HaiHe Biopharma. Class Alkaloids; Antineoplastics; Camptothecins; Esters; Small molecules. Mechanism of Action DNA topoisomerase I inhibitors; Hypoxia-inducible factor 1 inhibitors. Orphan Drug Status. Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. No.

WebHAIHE BIOPHARMA USA LLC: Conformed submission company name, business name, organization name, etc CIK: N/S (NOT SPECIFIED) Company's Central Index Key (CIK). …

WebHaihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs. Shanghai, Shanghai, China 251-500 Series B Private www.haihepharma.com/ 26,630 … trailmist rain jacketwomen by merrellWebMar 26, 2024 · Haihe Biopharma is a biopharmaceutical business that focuses on the development of anti-cancer medications. Details of the startup: Country: China; City: … trail mix 48 norththe scots school albury staffWebMar 7, 2024 · Haihe Biopharma Co., Ltd. ClinicalTrials.gov Identifier: NCT03457532 Other Study ID Numbers: SCC244-104 : First Posted: March 7, 2024 Key Record Dates: Last … the scots school albury parent loungeWebInvestors of HaiHe Biopharma include BioTrack Capital, CSPC, Atlas Capital, YINGKE PE, Legend Capital and 15 more. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. trail mix 25 pound bulk caseWebFeb 17, 2024 · Shanghai HaiHe Biopharma announced a $146.6 million funding to support its portfolio of innovative cancer drugs. HaiHe has partnered with Shanghai Institute of Materia Medica, Chinese Academy... the scots pgc college warwickWebProfile. Oral small molecule TKI targeting FGFR1-3, VEGFR1-3, PDGFR α/β, with significant efficacy and high safety Rapid oral absorption, with little food effects on PK Pivotal Phase II study ongoing in multiple sites nationwide for the treatment of various types of tumors Explore combinations with PD-1/PD-L1 antibody. Target. the scots school albury